hVIVO plc (LON:HVO – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 10.28 and traded as low as GBX 6. hVIVO shares last traded at GBX 6.05, with a volume of 934,267 shares traded.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the company. Peel Hunt reaffirmed an “add” rating and issued a GBX 10 price objective on shares of hVIVO in a research note on Tuesday, November 11th. Shore Capital cut their price target on shares of hVIVO from GBX 35 to GBX 25 and set a “buy” rating on the stock in a report on Tuesday, September 23rd. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, hVIVO currently has a consensus rating of “Buy” and a consensus price target of GBX 17.50.
View Our Latest Analysis on HVO
hVIVO Trading Up 0.8%
hVIVO (LON:HVO – Get Free Report) last released its quarterly earnings results on Tuesday, September 23rd. The company reported GBX (0.29) EPS for the quarter. hVIVO had a return on equity of 47.93% and a net margin of 25.96%. As a group, research analysts expect that hVIVO plc will post 1.5492958 EPS for the current fiscal year.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- Want to Profit on the Downtrend? Downtrends, Explained.
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to Calculate Stock Profit
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
